Every SEC Form 3/4/5 on record for this filer (CIK 1708764) — 3 issuers, 42 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| AVNS | AVANOS MEDICAL, INC. | Director | 2024-07-03 → 2026-05-12 | 3 | — |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | EVP, CLO & Secretary · lapsed | 2022-02-09 → 2024-02-29 | 7 | −$1M |
| ALXN | ALEXION PHARMACEUTICALS, INC. | EVP, Chief Compliance Officer · lapsed | 2017-06-09 → 2021-07-23 | 19 | −$2M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ALNY | 2024-02-28 | Sell | 66 | $156.38 | $10,321 | 4,143 |
| ALNY | 2024-02-28 | Sell | 111 | $155.45 | $17,255 | 4,209 |
| ALNY | 2024-02-28 | Sell | 142 | $154.54 | $21,945 | 4,320 |
| ALNY | 2024-02-28 | Sell | 1 | $158.09 | $158 | 4,133 |
| ALNY | 2024-02-28 | Sell | 9 | $157.30 | $1,416 | 4,134 |
| ALNY | 2024-02-02 | Sell | 269 | $172.38 | $46,370 | 3,584 |
| ALNY | 2024-02-02 | Sell | 820 | $171.14 | $140,335 | 3,853 |
| ALNY | 2024-02-02 | Sell | 502 | $170.01 | $85,345 | 4,673 |
2 of 3 issuers are covered and open a security page; the rest are on file here only.
